Clinical trial
A Prospective, Multicenter, Randomized, Parallel-Controlled, Subject- and Investigator-Masked, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Cross-Linked Hyaluronic Acid Gel for Injection in Correcting Moderate to Severe Nasolabial Folds
NCT07367204 is registered in ClinicalTrials.gov with Chongqing Jinsaixing Medical Technology Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Randomized, Parallel-Controlled, Subject- and Investigator-Masked, Non-Inferiority Clinical Trial to Evaluate the Efficacy and Safety of Cross-Linked Hyaluronic Acid Gel for Injection in Correcting Moderate to Severe Nasolabial Folds
- Lead sponsor
- Chongqing Jinsaixing Medical Technology Co., Ltd
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- February 24, 2025
- Completion date
- March 6, 2027
- Enrollment
- 356 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial fold wrinkles